Alpha Tau to Participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference

Rhea-AI Summary

Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) announced its participation in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on March 1, 2023, to be held at Citi HQ Conference Center in New York City.

The Alpha DaRT therapy, developed for treating solid tumors, utilizes radium-224 for targeted alpha-radiation intended to minimize damage to surrounding healthy tissue.

Founded in 2016, Alpha Tau focuses on advancing this innovative approach to cancer treatment, which was created by leading researchers from Tel Aviv University.

JERUSALEM, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on March 1, 2023 taking place at Citi HQ Conference Center in New York City.

Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference:
Date: Wednesday, March 1, 2023
Location: Citi HQ Conference Center

If you would like to schedule a 1:1 meeting, please contact your Citi representative.

About Alpha DaRT™

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.

About Alpha Tau Medical Ltd.

Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

Investor Relations Contact
IR@alphatau.com

FAQ

What is the date of Citi's 2023 Healthcare Services Conference involving Alpha Tau Medical Ltd.?

The conference is scheduled for March 1, 2023.

Where will the Citi Healthcare Services Conference take place?

The conference will be held at Citi HQ Conference Center in New York City.

What is Alpha DaRT and how does it work?

Alpha DaRT is a cancer therapy that uses radium-224 for delivering alpha radiation to solid tumors, aiming to destroy them while sparing healthy tissue.

What is the stock symbol for Alpha Tau Medical Ltd.?

The stock symbols are DRTS and DRTSW.

When was Alpha Tau Medical Ltd. founded?

Alpha Tau Medical Ltd. was founded in 2016.